Victoria Demartelly

Victoria Demartelly

Auto-generated profile, based on publicly available information

Victoria Demartelly

Department of Biobehavioral Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2023 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
ESEric S. Swirsky
Eric S. Swirsky
ABAndrew D. Boyd
Andrew D. Boyd
CGCarol Gu
Carol Gu
LBLarisa Ann Burke
Larisa Ann Burke
ADArdith Z. Doorenbos
Ardith Z. Doorenbos
JSJudith Michelle Schlaeger
Judith Michelle Schlaeger
Sickle cell disease (SCD) is a hemoglobin disorder and the most common genetic disorder that affects 100,000 Americans and millions worldwide. Adults living with SCD have pain so severe that it often requires opioids to keep it in control. Depression is a major global public health concern associated with an increased risk in chronic medical disorders, including in adults living with sickle cell disease (SCD). A strong relationship exists between suicidal ideation, suicide attempts, and depression. Researchers enrolling adults living with SCD in pragmatic clinical trials are obligated to design their methods to deliberately monitor and respond to symptoms related to depression and suicidal ideation. This will offer increased protection for their participants and help clinical investigators meet their fiduciary duties. This article presents a review of this sociotechnical milieu that highlights, analyzes, and offers recommendations to address ethical considerations in the development of protocols, procedures, and monitoring activities related to suicidality in depressed patients in a pragmatic clinical trial.

26 April 2023 in Women's Health Issues
Verified
Journal Article
Closed access
KEKaitlin Ellis
Kaitlin Ellis
KPKristin Pascoe
Kristin Pascoe
CACourtney Amegashie
Courtney Amegashie
ADAdrianne Dade
Adrianne Dade
VDVictoria Demartelly
Victoria Demartelly
JCJulie Chor
Julie Chor

20 January 2026 in Pain Management Nursing
Verified
Journal Article
Open access
SIStephanie O. Ibemere
Stephanie O. Ibemere
MKMitchell R. Knisely
Mitchell R. Knisely
IAIvy Akpotu
Ivy Akpotu
JDJuanita E. Darby
Juanita E. Darby
VMVictoria A. de Martelly
Victoria A. de Martelly
CPCrystal L. Patil
Crystal L. Patil
Even though there is clear evidence supporting the use of complementary and integrative health (CIH) interventions for chronic pain, their integration into clinical care is challenging. Thus, the purpose of this study was to understand how the integration of CIH interventions, namely, guided relaxation and acupuncture evaluated in the Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain (GRACE Trial), would impact clinic workflow at each study site. We conducted a qualitative descriptive study using individual interviews with healthcare providers and staff working at GRACE Trial sites. Interview data were analyzed using modified rapid qualitative analysis. We interviewed 13 healthcare providers from three GRACE Trial sites. Two major themes were identified: (1) the variable impact of CIH integration on clinic operations, and (2) the introduction of CIH interventions into clinical practice. This study highlights the importance and value of participatory approaches in integrating CIH interventions into healthcare settings. This study contributes to the CIH literature by addressing chronic pain and informing the identification of strategies to target the multi-layered challenges of integrating evidence-based CIH interventions into practice.

24 March 2026 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
MHMary F. Hannan
Mary F. Hannan
MFMichael J. Fischer
Michael J. Fischer
VDVictoria Demartelly
Victoria Demartelly
NLNatalie Lif
Natalie Lif
NTNathan Tintle
Nathan Tintle
ADArdith Z. Doorenbos
Ardith Z. Doorenbos
Fatigue has a profound negative impact on health for adults with end-stage kidney disease (ESKD) who receive maintenance hemodialysis. There are currently no standard-of-care therapies to alleviate this fatigue. Progressive muscle relaxation and physical activity have decreased fatigue in other populations. In collaboration with a patient partnership board, we developed an intervention aimed at reducing fatigue for adults receiving maintenance hemodialysis (Fight Fatigue), and we describe the protocol for its feasibility trial. Fight Fatigue was informed by our formative work with a patient partnership board (n = 3). Three virtual meetings were held, followed by 1:1 interviews with each board member. During the meetings, qualitative data was collected about the board's experience with fatigue and their feedback on the components of the intervention, which focused specifically on progressive muscle relaxation and increasing steps per day, as well as the study procedures. The Fight Fatigue intervention was developed informed by these findings. In the planned feasibility trial of this intervention, participants will be enrolled and randomized to either the Fight Fatigue intervention or an attention control. Data will be collected at baseline, week 6, and week 12. For this trial, the primary study endpoints are feasibility and acceptability, with a secondary endpoint of fatigue. The findings of this feasibility trial will inform the development of a randomized controlled trial of a combined mind-body and physical activity intervention to address fatigue for adults with ESKD receiving hemodialysis. NCT07014111.